| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |